United States Securities and Exchange Commission · EDGAR Accession 0002085093-26-000005

Form C-AR

Annual Report — Regulation Crowdfunding
Issuer CIK 2085093
Period 2025-12-31

CureValue, Inc.

CorporationDEIncorporated 2024WILMINGTON, DEcurevalue.org
B

Financial Condition

two fiscal years, as filed
0 employees
Line itemMost recent FYPrior FYΔ
Revenue37,0390
Cost of goods sold37,0390
Net income(59,919)0
Total assets6,9860
Cash & equivalents6,9860
Accounts receivable00
Short-term debt00
Long-term debt00
Taxes paid00

Figures in USD as reported by the issuer.